Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies.

These trends position Japan as a key player, with the market expected to grow at a CAGR of 10.5% during the forecast period.

The renewal for the ninth straight year includes McKesson's latest measure for resolution of health-related social needs.

An interprofessional team at Children's Hospital of Philadelphia is transforming CHOP's approach to fetal medicine through a ...

Inadequate Cervical Cancer Prevention and Care for Black Women in the United States Mississippi Delta,” documents that state ...